Cencora, Inc. (COR): Long-Term Debt
$7.66B
As of 2025-09-30
$11.72B
As of 2026-06-30
+10.3%
3-year compound annual growth
+13.2%
5-year compound annual growth
+8.2%
10-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $7.66B | +74.6% | 2025-11-25, Balance as of period end |
| 2024-09-30 | $4.39B | -8.3% | 2025-11-25, Balance as of period end |
| 2023-09-30 | $4.79B | -16.1% | 2024-11-26, Balance as of period end |
| 2022-09-30 | $5.70B | -14.7% | 2023-11-21, Balance as of period end |
| 2021-09-30 | $6.68B | +62.3% | 2022-11-22, Balance as of period end |
| 2020-09-30 | $4.12B | n/a | 2021-11-23, Balance as of period end |
| No annual figure between 2017-09-30 and 2020-09-30. | |||
| 2017-09-30 | $3.44B | -17.8% | 2017-11-21, Balance as of period end |
| 2016-09-30 | $4.19B | +19.9% | 2017-11-21, Balance as of period end |
| 2015-09-30 | $3.49B | +75.0% | 2016-11-22, Balance as of period end |
| 2014-09-30 | $2.00B | +42.9% | 2015-11-24, Balance as of period end |
| 2013-09-30 | $1.40B | 0.0% | 2014-11-25, Balance as of period end |
| 2012-09-30 | $1.40B | n/c | 2013-11-26, Balance as of period end |
| 2011-09-30 | $1.36B | +1.6% | 2012-11-27, Balance as of period end |
| 2010-09-30 | $1.34B | +14.1% | 2011-11-22, Balance as of period end |
| 2009-09-30 | $1.18B | n/a | 2010-11-23, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| Cencora, Inc. (COR) | 2025-09-30 | $7.66B | +74.6% |
| McKesson Corp (MCK) | 2026-03-31 | $6.53B | +15.4% |
| Herbalife Ltd. (HLF) | 2025-12-31 | $1.99B | -11.8% |
| Cosmos Health Inc. (COSM) | 2025-12-31 | $3.78M | -8.1% |
| DataMeds AI, Inc. (MEDS) | 2025-12-31 | $23.49M | +0.4% |
| Stemtech Corp (STEK) | 2025-12-31 | $4.16M | +9.1% |
Compare COR, MCK, HLF, COSM side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗